Zobrazeno 1 - 7
of 7
pro vyhledávání: '"N. I. Bohnen"'
Autor:
S. B. Wilkinson, D. S. Sax, K. Kompoliti, C. Eberly, L. M. Shulman, S. A. Factor, K. K. Zakzanis, M. Brewer, C. DeCarti, M. Takanashi, S. A. Alsdorf, K. Frey, M. R. Kilbourn, C. Comella, G. P. Bates, W. M. Chung, A. S. Menon, C. B. Moskowitz, R. Schwartz, J. M. Bertoni, Tatiana Foroud, John Seibyl, A. Minagar, J. Kieltyka, P. M. Conneally, R. A. Hauser, H. Ellgring, W. J. Weiner, S. W. Davies, R. Pahwa, L. Quinn, M. Freedman, R. Innis, A. Willing, E. Kaplan, N. I. Bohnen, Paul J. Tuite, T. Yanagihara, J. H J Cha, J. Hubble, F. Cardoza, G. Rouleau, L. Mangiarini, E. Aylward, M. Guttman, G. Ulm, A. B. Young, B. Pfeiffer, A. Malik, Juan Sanchez-Ramos, A. S. Frey, J. B. Penney, A. I. Troster, K. Abe, G. Bates, K. Francis, K. E. Lyons, Roger L. Albin, W. C. Koller, C. Kornetsky, M. Seeland, L. Leach, K. A. Frey, M. Baehr, R. A. Koeppe, Karl Kieburtz, David Oakes, G. W. Paulson, E. R. Siemers, Joanne Wojcieszek, L. W. Elmer, T. A. Zesiewicz, Kenneth Marek, D. Strickland, Mark Stacy
Publikováno v:
Movement Disorders. 13:858-863
Publikováno v:
Neurology. 83:102-103
Publikováno v:
European journal of neurology. 15(7)
The diagnosis of Parkinson disease (PD) is made typically on the basis of motor abnormalities. PD is now recognized to have both motor and non-motor manifestations, indicating a need for the development of reliable non-motor diagnostic tests for PD.
Autor:
K. Kawabe, K. Ikeda, Y. Iwasaki, E. Cereda, M. Barichella, G. Pezzoli, V. Kotagal, R. L. Albin, M. L. T. M. Muller, N. I. Bohnen
Publikováno v:
Neurology. 79:1835-1836
Editors' Note: Comments in Writ e Click this week were all in reference to “Clinical features of Parkinson disease when onset of diabetes came first: A case-control study” by Cereda et al. Drs. Kawabe et al. question whether differences in ischem
Autor:
N I, Bohnen, M, Charron
Publikováno v:
Clinical nuclear medicine. 26(2)
Publikováno v:
Nuklearmedizin. Nuclear medicine. 38(2)
A 41-year-old with a giant prolactinoma underwent in-111 pentetreotide (Octreotide) imaging showing very intense tracer uptake in the region of the anterior skull base. In contrast, there was no significant response to Octreotide therapy. Prediction
Publikováno v:
Nuklearmedizin. 38:66-67
SummaryA 41-year-old with a giant prolactinoma underwent ln-111 pentetreotide (Octreotide) imaging showing very intense tracer uptake in the region of the anterior skull base. In contrast, there was no significant response to Octreotide therapy. Pred